Q2 2021 Holdings
Filed 2021-08-10 | 399 holdings | $19.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cubesmart(CUBE) | COM | 229663109 | $1.8M | 38,560 | 9.3% |
| Conocophillips(COP) | COM | 20825C104 | $1.7M | 28,113 | 8.9% |
| Crown Castle Intl Corp New(CCI) | COM | 22822V101 | $1.7M | 8,618 | 8.7% |
| Cousins Pptys Inc(CUZ) | COM NEW | 222795502 | $1.6M | 42,483 | 8.1% |
| Barrick Gold Corp(ABX) | COM | 067901108 | $1.5M | 71,827 | 7.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $508.0K | 2,996 | 2.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $507.0K | 2,264 | 2.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $505.0K | 6,054 | 2.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $497.0K | 1,448 | 2.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $485.0K | 30,669 | 2.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $472.0K | 8,573 | 2.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $447.0K | 18,330 | 2.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $426.0K | 1,229 | 2.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $278.0K | 8,300 | 1.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $250.0K | 9,111 | 1.3% |
| Crescent Cap BDC Inc(CCAP) | COM | 225655109 | $249.0K | 13,248 | 1.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $235.0K | 10,385 | 1.2% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $232.0K | 61,284 | 1.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $230.0K | 8,817 | 1.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $229.0K | 30,187 | 1.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $228.0K | 7,509 | 1.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $223.0K | 3,313 | 1.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $223.0K | 11,810 | 1.2% |
| Alector Inc(ALEC) | COM | 014442107 | $220.0K | 10,556 | 1.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $219.0K | 1,664 | 1.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $218.0K | 5,724 | 1.1% |
| Annovis BIO Inc(ANVS) | COM | 03615A108 | $215.0K | 2,518 | 1.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $214.0K | 9,515 | 1.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $214.0K | 3,509 | 1.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $213.0K | 17,462 | 1.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $212.0K | 49,819 | 1.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $211.0K | 6,229 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $210.0K | 7,692 | 1.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $210.0K | 2,530 | 1.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $206.0K | 18,201 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $204.0K | 2,655 | 1.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $203.0K | 3,718 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $203.0K | 10,237 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $202.0K | 9,395 | 1.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $201.0K | 5,312 | 1.0% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $200.0K | 9,111 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $199.0K | 24,554 | 1.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $196.0K | 30,896 | 1.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $187.0K | 7,281 | 1.0% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $180.0K | 27,114 | 0.9% |
| North Amern Constr Group LTD(NOA) | COM | 656811106 | $2.0K | 134,360 | 0.0% |
| Phillips 66 Partners LP | COM UNIT REP INT | 718549207 | $2.0K | 50,060 | 0.0% |
| Imperial Oil LTD(IMO) | COM NEW | 453038408 | $1.9K | 63,901 | 0.0% |
| Steel Dynamics Inc(STLD) | COM | 858119100 | $1.9K | 32,451 | 0.0% |
| Valvoline Inc(VVV) | COM | 92047W101 | $1.9K | 57,505 | 0.0% |